Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2015
Pharmacokinetics of crizotinib in NSCLC patientsGerhard Hamilton, Barbara Rath, Otto BurghuberJournal of Cancer|August 19, 2017
In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesLukas Klameth, Barbara Rath, Gerhard HamiltonTranslational Lung Cancer Research|July 25, 2015
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cellsGerhard Hamilton, Barbara Rath, Otto BurghuberExploration of Targeted Anti-Tumor Therapy|November 29, 2023
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancerGerhard Hamilton, Sandra Stickler, Barbara RathOncoscience|October 2, 2015
How to target small cell lung cancerGerhard Hamilton, Barbara Rath, Ernst UlspergerCurrent Cancer Drug Targets|January 26, 2024
Bromodomain Protein-directed Agents and MYC in Small Cell Lung CancerGerhard Hamilton, Sandra Stickler, Barbara RathOncology Research|April 30, 2024
Targeting KRAS in pancreatic cancerSandra Stickler, Barbara Rath, Gerhard HamiltonExpert Review of Respiratory Medicine|August 5, 2024
Overcoming resistance in small-cell lung cancerGerhard Hamilton, Maximilian J Hochmair, Sandra SticklerCancers|November 12, 2013
Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen SuppressionGerhard Hamilton, Ulrike Olszewski-Hamilton, Gerhard TheyerOncology Research|July 26, 2024
Development of PROTACS degrading KRAS and SOS1Gerhard Hamilton, Marie-Therese Eggerstorfer, Sandra SticklerPageof 10